Kuano
Seedtable Score
34
Startups
1
Funding Rounds
2
Investors
$2.24m
Money raised
Overview
Kuano, based in London, offers a quantum simulation platform aimed at transforming drug discovery for biotech and health tech companies. Their B2B, SaaS model provides faster and more accurate simulations compared to traditional methods, potentially reducing timelines and costs. Supported by investors like Ascension Ventures and ACF Investors, Kuano leverages quantum computing to offer a competitive edge in a market dominated by longer, costlier processes. If successful, Kuano could significantly impact the development of new drugs.
- Website: https://kuano.ai
- Business model: b2b, saas
- Company size: 1 - 11 employees
- Headquarters: London, UK
- Founded: 2020
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (2)
Ascension Ventures
Climate Tech & Green Tech, Health Tech, Edtech, FinTech, Crypto & web3, ...
DetailsFunding
Funding series
Funding Series Analysis
The company Kuano has raised a total of $2.24m in funding over 1 rounds.
Key Insights:
- Seed: $2.24m
Kuano Seed (2023, $2M)
$2.24m